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http://dx.doi.org/10.1016/j.jfma.201Urinary tract infection (UTI) is traditionally classified as community-acquired (CA) and
hospital-acquired (HA). Community-onset health care-associated (HCA) infection is a new
category that has gained increasing attention. The study aimed to compare the disk suscep-
tibility of nonrepetitive Escherichia coli urinary isolates from HCA-UTI (n Z 100) with that of
E. coli isolates from CA-UTI (n Z 85) and HA-UTI (n Z 106). We found that the susceptibility
pattern of HCA-UTI E. coli isolates was similar to that of HA-UTI E. coli isolates, but signif-
icantly different from that of CA-UTI E. coli isolates. In particular, the proportion of
extended-spectrum b-lactamase-producing isolates was significantly higher in HCA-UTI than
that in CA-UTI (30.0% vs. 3.5%, p < 0.001). We recommend that when treating HCA-UTI,
it is necessary to take urine cultures for susceptibility testing to guide definite antibiotic
therapy.
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Urinary tract infection (UTI) is one of the most frequent
infectious diseases among hospital-acquired (HA) or
community-acquired (CA) infections. In order to achieve a
satisfactory therapeutic effect, it is suggested that local
information regarding the antimicrobial resistance of
frequent pathogens should be established as a reference
for the selection of empirical antimicrobial therapy.1,2
Microorganisms for CA-UTI are usually associated with a
lower level of antimicrobial resistance, whereas higher
resistance rates or, even worse, multidrug resistance are
rather common among HA-UTI pathogens.3 In the past few
decades, improvement in the medical management has
made some traditionally inpatient procedures to be deliv-
ered on an outpatient basis. Infections developed subse-
quent to these procedures are apparently not appropriate
to be categorized either as CA or HA infections, and hence
they have been named health care-associated (HCA) in-
fections.4 Recent studies indicated that community-onset
HCA infections are more similar to HA than to CA in-
fections.4,5 It also has been reported that the antimicrobial
resistance among HCA-UTI pathogens is much higher than
their counterparts associated with CA-UTI.6e8 In Taiwan,
although patients from the health care-associated settings
are increasing, reports regarding the antimicrobial resis-
tance in pathogens associated with HCA-UTI are rare. Still,
some reports have indicated that community-onset in-
fections in patients with prior hospitalization history or
frequent hospital exposures, as well as those residing in
nursing homes or referred from other health care facilities,
were more likely to be associated with resistant
microorganisms.9,10
The majority of CA-UTI (64.5-82%)6e8,11 or uncompli-
cated UTI (75-95%)2,12 are caused by Escherichia coli.
Therefore, empirical antimicrobial therapy for theTable 1 Comparison of antimicrobial susceptibilities among
extended-spectrum b-lactamase-producing isolates among variou
Antibiotics Susceptibility (%
All CA HC
(n Z 296) (n Z 85) (n Z
Total isolates
Cefazolin 25.7 49.4 13.0
Cefuroxime 54.7 85.9 44.0
Ceftriaxone 55.4 85.9 45.0
Ceftazidime 56.8 87.1 47.0
Ampicillin/sulbactam 40.5 71.8 32.0
Imipenem 99.3 100.0 100.0
Meropenem 99.3 100.0 99.0
Gentamicin 63.5 75.3 59.0
Amikacin 99.3 100.0 98.0
Levofloxacin 44.9 68.2 33.0
TMP/SMZ 43.2 55.3 37.0
ESBL-producing isolates 26.0 3.5 30.0
*Comparison by Chi-square test, with p < 0.05 indicating statistical s
CA Z community-acquired; ESBL Z extended-spectrum b-lactam
associated; NA Z not available; NS Z no statistical significance; TMPtreatment of such infections is usually based on the local
antimicrobial susceptibilities of this organism.2 Even with
complicated UTI, although the etiology may be complicated
by the deficiency in host factors, E. coli remains the most
frequent causative agent for such infections.13 As to HCA-
UTI or HA-UTI, although the reported bacterial spectra
may differ in various studies, E. coli is still one of the most
frequent pathogens.6e8,11 Unfortunately, the organism is
associated with an increasing antimicrobial resistance,
thereby adding difficulties in the selection of appropriate
agents for effective antimicrobial treatment.14 To differ-
entiate the antimicrobial susceptibilities associated with
UTI of different origins of acquisition, i.e., CA-UTI, HCA-
UTI, and HA-UTI, urinary isolates of E. coli were used as
representatives and analyzed herein.
Materials and methods
The study was performed at a 622-bed regional hospital in
southern Taiwan. In 2012, a total of 312 E. coli urinary
isolates were identified. Antimicrobial susceptibilities were
tested by a standard disk diffusion assay (Table 1). The
results were interpreted according to the criteria suggested
in 2012 by the Clinical Laboratory Standards Institute
(CLSI).15 However, according to a consensus statement
made by several professional societies in Taiwan,16 imipe-
nem and meropenem results were interpreted by using the
CLSI criteria suggested in 2009.17 Extended-spectrum b-
lactamase (ESBL) production among the isolates was also
examined with the confirmatory method suggested by the
CLSI without the change of cephalosporin susceptibility
results.17
The cases were further categorized according to the
following definitions. HA-UTI was defined if the case was
identified after 4 or more days of hospitalization. Among
the other non-HA-UTI cases, if the patients were residentsurinary isolates of Escherichia coli and the proportions of
s infection categories.
) p*
A HA CA vs. HCA vs.
100) (n Z 106) HCA HA HA
18.9 <0.001 <0.001 NS
41.5 <0.001 <0.001 NS
43.4 <0.001 <0.001 NS
44.3 <0.001 <0.001 NS
25.5 <0.001 <0.001 NS
98.1 NS NS NS
99.1 NS NS NS
60.4 <0.05 <0.05 NS
100.0 NS NA NS
38.7 <0.001 <0.001 NS
38.7 <0.05 <0.05 NS
34.9 <0.001 <0.001 NS
ignificance.
ase-producing; HA Z hospital-acquired; HCA Z health care-
/SMZ Z trimethoprim/sulfamethoxazole.
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within 90 days of discharge from a previous hospitalization
for 2 or more days, or within 30 days before the onset of the
UTI, the patients had indwelling urethral catheters, had
undergone any invasive urinary procedure, had received
hemodialysis or intravenous chemotherapy on an outpa-
tient basis, or had received specialized nursing care at
home by qualified health care providers, they would be
categorized as HCA-UTI.8,11 The other non-HA-UTI cases
that did not fulfill the HCA-UTI criteria and were from pa-
tients residing in the general community were categorized
as CA-UTI. Patients who were referred from another hos-
pital, although they may belong to HA-UTI, were not
included for further analysis in the present study.
All isolates or isolates in the respective subgroups were
further examined for duplication. If multiple isolates were
identified from the same patient during the same hospi-
talization period, only the first isolate was included for
analysis. If more than one E. coli isolates were identified
from the same specimen, the isolate with the higher anti-
microbial resistance would be selected for study.
For statistical analysis, the Chi-square test was used. A
difference was considered statistically significant when
p < 0.05.
Results
A total of 296 nonrepetitive E. coli urinary isolates were
analyzed (Table 1). High susceptibilities (>99%) were noted
in imipenem, meropenem, and amikacin. Susceptibilities to
other antimicrobial agents were all low at between 25.7%
to cefazolin and 63.5% to gentamicin.
When the isolates were further subcategorized, similar
conditions were found among isolates from the HA and HCA
groups. By contrast, CA isolates were relatively more sus-
ceptible to the antibiotics tested, and high susceptibilities
(>80%) could be noted in the second and third generation
cephalosporins (cefuroxime, ceftriaxone, and ceftazidime),
carbapenems (imipenem and meropenem), and amikacin.
Although the high susceptibilities to carbapenems and
amikacin were found in all groups, the susceptibilities to
cefuroxime, ceftriaxone, and ceftazidime were signifi-
cantly higher in CA isolates than in the others (p < 0.001).
Furthermore, susceptibilities to other antibiotics, such as
cefazolin, ampicillin/sulbactam, and levofloxacin, although
only ranged between 49.4% and 71.8%, were also signifi-
cantly higher in CA isolates than in the others (p < 0.001).
For gentamicin and trimethoprim/sulfamethoxazole, the
susceptibilities were also higher, although with a lower
significance, when isolates from the CA group were
compared with those from the HCA or HA groups (p < 0.05).
ESBL production was found in 26.0% of the isolates.
Although the proportion of such isolates was similar be-
tween the HCA and HA isolates, a significantly lower pro-
portion (3.5%) was noted in CA isolates (p < 0.001).
Discussion
Previous reports indicated that differences in the antimi-
crobial susceptibility patterns are present between CA-UTI/
HCA-UTI6,7 and between CA-UTI/HA-UTI.3 A few recentstudies also demonstrated the differences among clinical
and microbiological characteristics in patients with CA-UTI,
HCA-UTI, and HA-UTI.8,11 In the present study, using E. coli
urinary isolates as the representative, we further demon-
strated that antimicrobial susceptibilities of HCA-UTI iso-
lates were similar to those of HA-UTI isolates but were
significantly lower than those of CA-UTI isolates. The re-
sults echoed the findings in a recent report8 and suggested
that despite the initial empirical antibiotic therapy, urine
cultures for antimicrobial susceptibility testing are
required, especially for HCA-UTI, to guide the subsequent
definite antibiotic therapy.
In the present study, the majority of the patients in the
HCA-UTI group were residents of nursing homes and pa-
tients re-admitted within 90 days of discharge from a pre-
vious hospitalization. Previous reports indicated that
nursing home residents are usually associated with high
age, various underlying illnesses, and immobility.18
Compared to other community dwellers, hospital visits
are relatively more frequent or sometimes inevitable
among these patients.18 Frequent hospitalization also pro-
vides the patients with close contact of the hospital envi-
ronment. Consequently, when an infection, such as UTI,
occurs, the associated pathogens may be more likely to be
related to hospitals, that is, HAI pathogens, although the
patients are not hospitalized at the onset of the infection.
Under such circumstances, the appropriate empirical anti-
microbial agents should be similar for HCA-UTI and HA-UTI
patients. However, without such awareness, HCA-UTI
would likely be treated as CA-UTI because the patients
were literally from a nonhospital environment. Failure in
clinical recognition may lead to inadequate antibiotic
therapy,19 especially for the treatment of severe compli-
cated HCA-UTI, and the subsequent adverse outcomes may
be expected.20 Therefore, patients with HCA-UTI should be
differentiated from those with CA-UTI, and accordingly, the
antimicrobial susceptibilities of HCA-UTI isolates should be
analyzed independently.
In consistence with a consensus review of the epidemi-
ology and appropriate antimicrobial therapy of complicated
UTI in Asia-Pacific region,1 data on CA-UTI in our hospital
support the view that care should be taken when using
trimethoprim/sulfamethoxazole or fluoroquinolones for
empirical treatment of CA-UTI, particularly complicated
CA-UTI in moderately to severely ill patients. Furthermore,
empirical antibiotics for the treatment of serious compli-
cated UTIs in which risk factors for resistant organisms exist
should include broad-spectrum antibiotics, such as imipe-
nem or meropenem.
In conclusion, using E. coli as the representative organ-
ism, the present study demonstrated the differences in
antimicrobial susceptibilities among CA-UTI, HCA-UTI, and
HA-UTI isolates. Clinicians should be aware that non-HA-UTI
in patients who have frequent health care contacts, i.e.,
HCA-UTI, is likely to be associated with higher antimicrobial
resistance similar to those observed in HA-UTI. Further-
more, considerable variability in the antimicrobial suscep-
tibility patterns may also exist among the frequent
pathogens of various infections, in different patient pop-
ulations, and from diverse institutions. Local antimicrobial
susceptibility patterns are therefore critical and should be
established respectively for the effective management of
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ered when prescribing empirical antibiotics, urine cultures
for susceptibility testing are still required, especially for
HCA-UTI patients, to guide the subsequent definite antibi-
otic therapy.
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